Tadalafil Tablet, Film Coated
Product Images NDC 71335-1587

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Tadalafil (NDC 71335-1587). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl713351587)

This is a description of a medication. The medication is Tadalafil 20mg yellow OVAL FJ4. It is a substitute for Cialis 20mg Tablet. The manufacturer is Intas Pharmaceuticals Limited, and it comes in a bottle of 30 tablets. It is recommended to store it at a room temperature of 20°-25°C (68°-77°F) and away from children's reach.*

FDA Label Image

Figure (Tadalafil Figure1)

The text is a table displaying the difference in blood pressure (standing systolic and diastolic, supine systolic and diastolic) for Tadalafil minus Placebo in mmHg over time in hours.*

FDA Label Image

Figure (Tadalafil Figure2)

The text describes a chart or graph showing the results of a study involving two drugs, one containing Tadalafil 20mg and Doxazosin 8mg and the other containing only Doxazosin 8mg and a placebo. The x-axis represents time post-dose in hours, while the y-axis is not available due to the limited nature of the text. There are also numerical values in the text, such as "10", "3", "5", and various values for "2E". It is unclear what the values refer to without additional context.*

FDA Label Image

Figure (Tadalafil Figure3)

The text describes a chart that shows the effects of taking tadalafil and doxazosin on systolic blood pressure at different times after administration. Four different scenarios are presented: taking 20mg of tadalafil and 8mg of doxazosin at 8 am, taking a placebo and 8mg of doxazosin at 8 am, taking 20mg of tadalafil and 8mg of doxazosin at 8 pm, and taking a placebo and 8mg of doxazosin at 8 pm. The chart shows the systolic blood pressure in mmHg at 10 and 20 minutes after taking the medication/placebo. No other information is available.*

FDA Label Image

Figure (Tadalafil Figure4)

This is a chart showing the plasma concentration of Tadalafil in ug/L over time (in hours) after administering a single 20-mg dose, a single 5-mg dose, and once-daily 5-mg doses for five consecutive days. The concentration ranges from 500ug/L to 100ug/L.*

FDA Label Image

Figure 5 (Tadalafil Figure5)

This text is a graph showing the change from baseline in IPSS total score for a treatment with tadalafil and placebo over 12 weeks. The y-axis scale is not visible in the text provided. The text indicates that there was a statistically significant difference (p<0.01) between the two groups.*

FDA Label Image

Figure 6 (Tadalafil Figure6)

FDA Label Image

Figure 7 (Tadalafil Figure7)

FDA Label Image

Figure 8 (Tadalafil Figure8)

FDA Label Image

Chemical Structure (Tadalafil Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.